Patent details

Basic Information

Publication number:

EP1278824

PCT Application Number:

PCT/CA/2001/000620

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019312511

PCT Publication Number:

WO/2001/083711

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CLEARANCE OF RAS-MEDIATED NEOPLASTIC CELLS FROM MIXED CELLULAR COMPOSITIONS USING REOVIRUS

French Title of Invention:

CLAIRANCE PAR REOVIRUS DES CELLULES NEOPLASIQUES A MEDIATION DES RAS ISSUES DE COMPOSITIONS CELLULAIRES MIXTES

German Title of Invention:

ENTFERNUNG VON RAS-VERMITTELTEN NEOPLASTISCHEN ZELLEN AUS GEMISCHTEN ZELLULÄREN ZUSAMMENSETZUNGEN MITTELS REOVIREN

SPC Number:

Dates

Filing date:

02/05/2001

Grant date:

14/07/2010

EP Publication Date:

14/07/2010

PCT Publication Date:

08/11/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/01/2003

EP B1 Publication Date:

14/07/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/05/2011

Expiration date:

02/05/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/05/2001

 

 

Name:

Oncolytics Biotech Inc.

Address:

Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)

Inventor

1

Name:

MORRIS Donald

Address:

Canada (CA)

2

Name:

THOMPSON Bradley, G.

Address:

Canada (CA)

3

Name:

COFFEY Matthew, C.

Address:

Canada (CA)

Priority

1

Priority Number:

201990 P

Priority Date:

03/05/2000

Priority Country:

United States (US)

2

Priority Number:

205389 P

Priority Date:

19/05/2000

Priority Country:

United States (US)

3

Priority Number:

268054 P

Priority Date:

13/02/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 5/078;

Filing date	Document type	Number of pages